Mark J. Rosenblum
2023 - Flex Pharma
In 2023, Mark J. Rosenblum earned a total compensation of $355.8K as Executive Vice President, Finance and Chief Financial Officer at Flex Pharma, a 28% decrease compared to previous year.
Compensation breakdown
| Salary | $330,000 |
|---|---|
| Stock Awards | $12,560 |
| Other | $13,200 |
| Total | $355,760 |
Rosenblum received $330K in salary, accounting for 93% of the total pay in 2023.
Rosenblum also received $12.6K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Mark J. Rosenblum's compensation ranked 2,387th out of 3,006 executives tracked by ExecPay. In other words, Rosenblum earned more than 20.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,387 out of 3,006 | 21st |
Division Manufacturing | 1,344 out of 1,650 | 19th |
Major group Chemicals And Allied Products | 791 out of 918 | 14th |
Industry group Drugs | 772 out of 881 | 12th |
Industry Pharmaceutical Preparations | 556 out of 637 | 13th |
Source: SEC filing on November 1, 2024.
Rosenblum's colleagues
We found one more compensation record of an executive who worked with Mark J. Rosenblum at Flex Pharma in 2023.
2023
David and
Flex Pharma